Can Assertive Treatment Improve Treatment Adherence in Young Adults With Opioid Use Disorder?

Topics: Adherence | Opioid Use Disorder | Randomized controlled trial | Youth

Review of: Fishman M et al, Addiction 2020 Jul 4. https://doi.org/10.1111/add.15181 We often use injectable extended-release naltrexone (XR-NTX, or Vivitrol) for management of opioid use disorder (OUD). However, XR-NTX has not been widely used in young adults with OUD, possibly due to low patient engagement and treatment adherence. This study evaluat